Literature DB >> 202522

Cell-mediated immunity to vesicular stomatitis virus infections in mice.

R M Zinkernagel, B Adler, J J Holland.   

Abstract

The T cell-mediated immune responses of mice against vesicular stomatitis virus (VSV) were assessed by measuring direct primary foot pad swelling after local VSV infection and cytotoxic activity in spleens. The cytolytic activity was mediated by T cells since it was anti-theta + complement sensitive, was restricted by the K and D region but not the I region of H-2 and rapidly increased after 4 days but decreased 8 days after systemic or local infection. Cytolytic activity was virus-specific as reciprocally tested with VSV and vaccina virus immune T cells. Measurable activity on day 7 depended on infectious virus dose, virus virulence, and non-H-2 genetic background of the host. More than half of the cytolytic activity wasblocked specifically by either immune anti-H2 or rabbit anti-VSV antisera. Analysis of the kinetics of appearance of antigenic changes using metabolic inhibitors, revealed that the changes that rendered target cells susceptible to lysis after infection, occurred within the first hour after infection.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 202522     DOI: 10.1159/000162882

Source DB:  PubMed          Journal:  Exp Cell Biol        ISSN: 0304-3568


  28 in total

1.  Skin test to assess virus-specific cytotoxic T-cell activity.

Authors:  T M Kündig; A Althage; H Hengartner; R M Zinkernagel
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

2.  Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses.

Authors:  Michael Garbutt; Ryan Liebscher; Victoria Wahl-Jensen; Steven Jones; Peggy Möller; Ralf Wagner; Viktor Volchkov; Hans-Dieter Klenk; Heinz Feldmann; Ute Ströher
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

Review 3.  Avian influenza pandemic preparedness: developing prepandemic and pandemic vaccines against a moving target.

Authors:  Neetu Singh; Aseem Pandey; Suresh K Mittal
Journal:  Expert Rev Mol Med       Date:  2010-04-29       Impact factor: 5.600

4.  Vesicular Stomatitis Virus-Based Vaccines for Prophylaxis and Treatment of Filovirus Infections.

Authors:  Andrea Marzi; Heinz Feldmann; Thomas W Geisbert; Darryl Falzarano
Journal:  J Bioterror Biodef       Date:  2011-09-25

5.  Identification of an immunodominant cytotoxic T-lymphocyte recognition site in glycoprotein B of herpes simplex virus by using recombinant adenovirus vectors and synthetic peptides.

Authors:  T Hanke; F L Graham; K L Rosenthal; D C Johnson
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

6.  Fewer protective cytotoxic T-cell epitopes than T-helper-cell epitopes on vesicular stomatitis virus.

Authors:  T M Kündig; I Castelmur; M F Bachmann; D Abraham; D Binder; H Hengartner; R M Zinkernagel
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

7.  Generation of hepatitis C virus-like particles by use of a recombinant vesicular stomatitis virus vector.

Authors:  Heather J Ezelle; Dubravka Markovic; Glen N Barber
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

8.  B cell maintenance of subcapsular sinus macrophages protects against a fatal viral infection independent of adaptive immunity.

Authors:  E Ashley Moseman; Matteo Iannacone; Lidia Bosurgi; Elena Tonti; Nicolas Chevrier; Alexei Tumanov; Yang-Xin Fu; Nir Hacohen; Ulrich H von Andrian
Journal:  Immunity       Date:  2012-03-01       Impact factor: 31.745

9.  A chimeric vesiculo/alphavirus is an effective alphavirus vaccine.

Authors:  Anasuya Chattopadhyay; Eryu Wang; Robert Seymour; Scott C Weaver; John K Rose
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

10.  Activation of mouse lymphocytes by vesicular stomatitis virus.

Authors:  G W Goodman-Snitkoff; J J McSharry
Journal:  J Virol       Date:  1980-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.